Peer Review History
| Original SubmissionAugust 6, 2025 |
|---|
|
PNTD-D-25-01140 Community-wide deworming strategies to reduce high hookworm burden in endemic communities: Results from a cluster randomized trial in southern India PLOS Neglected Tropical Diseases Dear Dr. Ajjampur, Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within by Jan 05 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Michael Cappello, M.D. Academic Editor PLOS Neglected Tropical Diseases Francesca Tamarozzi Section Editor PLOS Neglected Tropical Diseases Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-4304-636XX Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-1765-0002 Additional Editor Comments: The manuscript has been reviewed and I concur with the issues raised. Overall this is a well designed and implemented study. However, there are questions raised by the reviewer about the methods and results that when addressed will provide greater clarity. In addition, a revised manuscript should address the "overarching question" raised by the reviewer regarding the low prevalence of moderate to high intensity infections in the study population. The authors should explain how this affects interpretation of the findings of the study and implications for extrapolating results to other endemic communities. Journal Requirements: 1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full. At this stage, the following Authors/Authors require contributions: Rohan Michael Ramesh, Rajiv Sarkar, Vasanthakumar Velusamy, Srinivasan Venugopal, Anuradha Rose, Venkata R. Mohan, Vinohar Balraj, Vedantam Rajshekhar, Kuryan George, Jayaprakash Muliyil, Nicholas C. Grassly, Simon J. Brooker, Roy M. Anderson, Gagandeep Kang, and Sitara Swarna Rao Ajjampur. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form. The list of CRediT author contributions may be found here: https://journals.plos.org/plosntds/s/authorship#loc-author-contributions 2) Tables should not be uploaded as individual files. Please remove these files and include the Tables in your manuscript file as editable, cell-based objects. For more information about how to format tables, see our guidelines: https://journals.plos.org/plosntds/s/tables Reviewers' Comments: Reviewer's Responses to Questions Key Review Criteria Required for Acceptance? As you describe the new analyses required for acceptance, please consider the following: Methods: -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? -Is the population clearly described and appropriate for the hypothesis being tested? -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? -Were correct statistical analysis used to support conclusions? -Are there concerns about ethical or regulatory requirements being met? Reviewer #1: Objectives are clear, study design is appropriate. Details are needed on the selection and participation in the coprological survey. Please clarify how the random subset of participants were selected? Were they selected at the household level? At the community level? Any stratification by age? What proportion of the community were selected? Were participants from each community recruited proportional to population? Please clarify the timing of the follow up in the three sets of treatment villages. Was the pre-intervention synchronized across the three treatments? And then three month post-intervention was staggered across the three treatments (i.e. 3 months after single cycle, three months after end of second cycle (one month after 1st treatment group), and three months after end of fourth cycle (8 months after the single cycle group)? Any seasonal impacts on transmission in the study communities? ********** Results: -Does the analysis presented match the analysis plan? -Are the results clearly and completely presented? -Are the figures (Tables, Images) of sufficient quality for clarity? Reviewer #1: Please provide demographic details on the participants in the coprological surveys across the timepoints. These could be included as a supplemental file; but important to see the characteristics of the participants on whom the prevalence and intensity data are based. ********** Conclusions: -Are the conclusions supported by the data presented? -Are the limitations of analysis clearly described? -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? -Is public health relevance addressed? Reviewer #1: Discussion: Line 354-357 – Results conclude no statistically significant difference between three different treatment groups 24 months after intervention (lines 318-320); Lines 354-357 assert significantly lower prevalence and intensity after four cycles. Please integrate the nuance here that is repeated in the next paragraph, of the difference no longer being apparent at 24 months. Consider including the limitation that the criteria for WHO elimination as a public health problem were met prior to onset of the study. ********** Editorial and Data Presentation Modifications? Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”. Reviewer #1: Minor issues: Line 68 – ‘along-with’ doesn’t need a hyphen. Line 75-76 – please clarify what the appropriate reference is. Findings from large-scale community intervention trials are referenced in citations 11 and 12, but 12 is a global modeling study, not a large-scale community intervention trial. ********** Summary and General Comments: Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed. Reviewer #1: Community-wide deworming strategies to reduce high hookworm burden in endemic communities: Results from a cluster randomized trial in southern India This study reports on an open-label, cluster-randomized community-intervention trial comparing community hookworm burden with a single cycle of albendazole MDA, two cycles one month apart, and four-cycles of single dose albendazole MDA (two cycles one month apart followed by two more cycles one month apart six months later). Authors randomly assigned 45 villages to one of the three treatments. Outcome was hookworm prevalence and mean intensity of infection at 12 months post-MDA. Overarching question – Given the emphasis on achieving and sustaining the WHO target for STH elimination as a public health problem (<2% prevalence of moderate-to-heavy intensity infections, line 418-419), it seems the study villages met that criteria at the onset of the study (line 262-263; <1.2% moderate to heavy intensity infections). How do you think that baseline condition affects the generalizability of your work to higher intensity communities? ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy.. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix. After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols |
| Revision 1 |
|
Dear Professor Ajjampur, We are pleased to inform you that your manuscript 'Community-wide deworming strategies to reduce high hookworm burden in endemic communities: Results from a cluster randomized trial in southern India' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Michael Cappello, M.D. Academic Editor PLOS Neglected Tropical Diseases Francesca Tamarozzi Section Editor PLOS Neglected Tropical Diseases Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-4304-636XX Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-1765-0002 *********************************************************** Thank you for responding to the comments on the original submission. The revised manuscript is much improved and suitable for publication. |
| Formally Accepted |
|
Dear Professor Ajjampur, We are delighted to inform you that your manuscript, "Community-wide deworming strategies to reduce high hookworm burden in endemic communities: Results from a cluster randomized trial in southern India," has been formally accepted for publication in PLOS Neglected Tropical Diseases. We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .